blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1147085

EP1147085 - ALKYNYL CONTAINING HYDROXAMIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS / TNF-ALPHA CONVERTING ENZYME (TACE) INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.09.2006
Database last updated on 03.04.2025
Most recent event   Tooltip05.12.2008Lapse of the patent in a contracting state
New state(s): CY
published on 07.01.2009  [2009/02]
Applicant(s)For all designated states
Wyeth Holdings Corporation
Five Giralda Farms
Madison, NJ 07940 / US
[2003/18]
Former [2001/43]For all designated states
American Cyanamid Company
Five Giralda Farms
Madison, New Jersey 07940-0874 / US
Inventor(s)01 / LEVIN, Jeremy, Ian
19 Long Meadow Drive
New City, NY 10956 / US
02 / VENKATESAN, Aranapakam, Mudumbai
97-07, 63rd Road 9K
Rego Park, NY 11374 / US
03 / CHEN, James, Ming
7 Sergeant David Stoddard Court
Bedminster, NJ 07921 / US
04 / ZASK, Arie
21 East 90 Street
New York, NY 10128 / US
05 / SANDANAYAKA, Vincent, Premarana
1 Earl Court
Wesley Hills, NY 10952 / US
06 / DU, Mila, Ti
17 Heather Hill Lane
Suffern, NY 10901 / US
07 / BAKER, Jannie, Lea
127 Rockinchair Road
White Plains, NY 10607 / US
 [2001/43]
Representative(s)Wileman, David Francis, et al
C/o Wyeth Laboratories Huntercombe Lane South Taplow Maidenhead
Berkshire SL6 OPH / GB
[N/P]
Former [2001/43]Wileman, David Francis, Dr., et al
c/o Wyeth Laboratories Huntercombe Lane South
Taplow Maidenhead Berkshire SL6 OPH / GB
Application number, filing date00904569.127.01.2000
[2001/43]
WO2000US01864
Priority number, dateUS1999023803827.01.1999         Original published format: US 238038
[2001/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0044723
Date:03.08.2000
Language:EN
[2000/31]
Type: A1 Application with search report 
No.:EP1147085
Date:24.10.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 03.08.2000 takes the place of the publication of the European patent application.
[2001/43]
Type: B1 Patent specification 
No.:EP1147085
Date:16.11.2005
Language:EN
[2005/46]
Search report(s)International search report - published on:EP03.08.2000
ClassificationIPC:C07D211/66, A61K31/445, C07D309/08, A61K31/35, C07D401/06, C07D409/06, C07D401/12, C07D413/04, C07D407/06, A61P19/00, A61P19/02
[2001/43]
CPC:
C07D309/08 (EP,US); A61K31/351 (EP,US); A61K31/435 (EP,US);
A61K31/445 (EP,US); A61K31/496 (EP,US); A61P19/00 (EP);
A61P19/02 (EP); C07D211/60 (EP,US); C07D211/62 (EP,US);
C07D211/66 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/43]
Extension statesAL27.06.2001
LT27.06.2001
LV27.06.2001
MKNot yet paid
RO27.06.2001
SI27.06.2001
TitleGerman:ALKYNYL SUBSTITUIERTE HYDROXAMSÄURE DERIVATE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS MATRIX METALLOPROTEINASE (MMP) INHIBITOREN / TNF-ALPHA CONVERTING ENZYME (TACE) INHIBITOREN[2001/43]
English:ALKYNYL CONTAINING HYDROXAMIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS / TNF-ALPHA CONVERTING ENZYME (TACE) INHIBITORS[2001/43]
French:DERIVES D'ACIDE HYDROXAMIQUE ALKYNYLES, LEUR ELABORATION ET LEUR UTILISATION COMME INHIBITEURS DES METALLOPROTEINASES MATRICES OU INHIBITEURS DES TACE (ENZYMES DE CONVERSION DU FACTEUR DE NECROSE TUMORALE ALPHA)[2001/43]
Entry into regional phase27.06.2001National basic fee paid 
27.06.2001Designation fee(s) paid 
27.06.2001Examination fee paid 
Examination procedure26.07.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
27.06.2001Examination requested  [2001/43]
21.11.2002Despatch of a communication from the examining division (Time limit: M08)
08.09.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
09.10.2003Reply to a communication from the examining division
13.05.2004Despatch of a communication from the examining division (Time limit: M04)
23.09.2004Reply to a communication from the examining division
17.05.2005Communication of intention to grant the patent
14.09.2005Fee for grant paid
14.09.2005Fee for publishing/printing paid
Opposition(s)17.08.2006No opposition filed within time limit [2006/43]
Request for further processing for:09.10.2003Request for further processing filed
09.10.2003Full payment received (date of receipt of payment)
Request granted
27.10.2003Decision despatched
Fees paidRenewal fee
10.01.2002Renewal fee patent year 03
09.01.2003Renewal fee patent year 04
05.01.2004Renewal fee patent year 05
07.01.2005Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT16.11.2005
BE16.11.2005
CH16.11.2005
CY16.11.2005
FI16.11.2005
FR16.11.2005
IT16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GB16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
[2009/02]
Former [2008/52]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
FR16.11.2005
IT16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GB16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2008/40]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
IT16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
FR31.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GB16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2007/35]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
IT16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GB16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2007/27]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GB16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2007/08]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
LU31.01.2006
MC31.01.2006
DK16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2006/51]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
MC31.01.2006
DK16.02.2006
GR16.02.2006
SE16.02.2006
DE17.02.2006
ES27.02.2006
PT17.04.2006
Former [2006/48]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
IE27.01.2006
MC31.01.2006
DK16.02.2006
GR16.02.2006
SE16.02.2006
ES27.02.2006
PT17.04.2006
Former [2006/44]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
MC31.01.2006
DK16.02.2006
GR16.02.2006
SE16.02.2006
ES27.02.2006
Former [2006/38]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
DK16.02.2006
GR16.02.2006
SE16.02.2006
ES27.02.2006
Former [2006/36]AT16.11.2005
BE16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
DK16.02.2006
SE16.02.2006
ES27.02.2006
Former [2006/34]AT16.11.2005
CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
DK16.02.2006
SE16.02.2006
ES27.02.2006
Former [2006/33]CH16.11.2005
FI16.11.2005
LI16.11.2005
NL16.11.2005
SE16.02.2006
ES27.02.2006
Former [2006/27]FI16.11.2005
NL16.11.2005
SE16.02.2006
Former [2006/23]FI16.11.2005
NL16.11.2005
Cited inInternational search[DX]WO9837877  (AMERICAN CYANAMID CO [US]) [DX] 3-7 * claims 1-3,14-19 *;
 [PX]WO9942436  (AMERICAN CYANAMID CO [US]) [PX] 3-7 * claims 1-3,37-42 *;
 [DA]WO9724117  (RHONE POULENC RORER PHARMA [US], et al) [DA] 3-7 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.